Uncategorized
Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences: Cowen 41st Annual Health Care Conference Date: Monday, March 1, 2021 Analyst-hosted fireside chat: 12:30 PM ET Raymond James 42nd Annual Institutional Investors Conference Date: Wednesday, March 3, 20